4//SEC Filing
Bartram Richard 4
Accession 0001628280-21-013223
CIK 0001434868other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 4:27 PM ET
Size
8.0 KB
Accession
0001628280-21-013223
Insider Transaction Report
Form 4
Bartram Richard
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2021-06-28+37,500→ 37,500 totalExercise: $22.52Exp: 2031-06-28→ Common Stock (37,500 underlying) - Award
Performance-based Restricted Stock Units
2021-06-28+26,400→ 26,400 totalExp: 2023-06-30→ Common Stock (26,400 underlying)
Footnotes (3)
- [F1]Such award will vest over a four (4) year period in equal quarterly installments, the first of which will be October 15, 2021.
- [F2]Each Performance-Based Restricted Stock Unit represents a contingent right to receive one share of Esperion Therapeutics, Inc. common stock.
- [F3]These shares were issued in connection with a reward of performance-based restricted stock units that will vest only if performance goals are achieved over a two-year period beginning July 1, 2021. The actual number of units (if any) received under this award will depend on continued employment and actual performance over the two-year performance period.
Documents
Issuer
Esperion Therapeutics, Inc.
CIK 0001434868
Entity typeother
Related Parties
1- filerCIK 0001723729
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 4:27 PM ET
- Size
- 8.0 KB